MY Stock MarketDetailed Quotes
7081 PHARMA
- 0.385
- +0.010+2.67%
15min DelayTrading Dec 2 09:05 CST
554.87MMarket Cap5.92P/E (TTM)
0.390High0.385Low584.70KVolume0.390Open0.375Pre Close227.60KTurnover0.47052wk High0.13%Turnover Ratio1.44BShares0.29552wk Low0.065EPS TTM178.34MFloat Cap1.267Historical HighLossP/E (Static)463.23MShs Float0.067Historical Low-0.059EPS LYR1.33%Amplitude--Dividend TTM-3.18P/B100Lot Size--Div YieldTTM
PHARMA Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 16.30%1.03B | -1.23%838.26M | 9.60%964.96M | -2.20%3.4B | -8.45%789.81M | -1.06%885.49M | 11.51%848.73M | -8.49%880.45M | -27.71%3.48B | 21.22%862.72M |
| Cost of revenue | 3.50%802.35M | 0.39%754.69M | 7.04%841.65M | -16.09%3.1B | -41.64%783.39M | -6.10%775.22M | 11.16%751.76M | -7.10%786.29M | -11.82%3.69B | 142.01%1.34B |
| Gross profit | 106.29%227.47M | -13.82%83.57M | 30.95%123.31M | 246.87%307.82M | 101.34%6.42M | 59.01%110.27M | 14.30%96.97M | -18.69%94.17M | -133.27%-209.59M | -405.32%-479.58M |
| Operating expense | -52.48%71.76M | -15.76%63.98M | -6.11%67.84M | 4.33%328.01M | -70.82%28.79M | 104.03%151.01M | 6.94%75.94M | 2.21%72.26M | -2.46%314.39M | 291.71%98.66M |
| Selling and administrative expenses | ---- | ---- | ---- | 4.31%328.27M | ---- | ---- | ---- | ---- | -2.46%314.72M | ---- |
| -General and administrative expense | ---- | ---- | ---- | 4.31%328.27M | ---- | ---- | ---- | ---- | -2.46%314.72M | ---- |
| Other operating expenses | -52.48%71.76M | -15.76%63.98M | -6.11%67.84M | ---- | ---- | 104.03%151.01M | 6.94%75.94M | 2.21%72.26M | ---- | ---- |
| Total other operating income | ---- | ---- | ---- | -21.15%261K | ---- | ---- | ---- | ---- | -2.65%331K | ---- |
| Operating profit | 482.14%155.71M | -6.85%19.59M | 153.19%55.47M | 96.15%-20.19M | 96.13%-22.37M | -772.34%-40.75M | 52.14%21.03M | -51.44%21.91M | -270.28%-523.97M | -538.43%-578.24M |
| Net non-operating interest income (expenses) | -9.60%-17.37M | -16.02%-17.67M | -27.13%-16.93M | -54.28%-60.37M | -29.96%-15.96M | -64.90%-15.85M | -62.65%-15.23M | -69.30%-13.32M | -23.04%-39.13M | -67.50%-12.28M |
| Non-operating interest income | 148.04%888K | 256.16%520K | -32.13%450K | 62.31%1.48M | 30.25%310K | 184.13%358K | -33.64%146K | 103.37%663K | -40.25%910K | -57.73%238K |
| Non-operating interest expense | 12.65%18.26M | 18.30%18.19M | 24.32%17.38M | 54.46%61.84M | 29.97%16.27M | 66.44%16.21M | 60.44%15.38M | 70.66%13.98M | 20.15%40.04M | 58.57%12.52M |
| Net investment income | 2,583.33%1.13M | -95.47%42K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 101.72%864K | -70,836.62%-50.22M | ||||||||
| Less:Impairment of capital assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --50.27M | ---- |
| Less:Other special charges | ---- | ---- | ---- | -1,594.12%-864K | ---- | ---- | ---- | ---- | 28.17%-51K | ---- |
| Less:Write off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | -56.51%147K | 158.55%1.42M | -15.54%511K | -85.26%397K | -147.53%-1.1M | 160.00%338K | 720.90%550K | 216.75%605K | 1,532.73%2.69M | 594.85%2.31M |
| Income before tax | 346.16%138.49M | -47.43%3.33M | 324.71%39.04M | 87.20%-78.16M | 94.14%-37.44M | -297.51%-56.26M | 40.28%6.34M | -75.45%9.19M | -320.37%-610.59M | -610.36%-638.4M |
| Income tax | 615.34%37.17M | -112.74%-512K | 100.17%12.87M | -96.60%581K | -145.71%-2.65M | -678.83%-7.21M | 11.39%4.02M | -25.12%6.43M | -83.73%17.07M | -85.47%5.8M |
| Net income | 306.58%101.32M | 65.49%3.85M | 846.46%26.18M | 87.45%-78.74M | 94.60%-34.79M | -270.81%-49.05M | 154.27%2.32M | -90.41%2.77M | -464.48%-627.65M | -856.41%-644.2M |
| Net income continuous operations | 306.58%101.32M | 65.49%3.85M | 846.46%26.18M | 87.45%-78.74M | 94.60%-34.79M | -270.81%-49.05M | 154.27%2.32M | -90.41%2.77M | -464.48%-627.65M | -856.41%-644.2M |
| Noncontrolling interests | -1.71%287K | 188.98%1.05M | 351.69%533K | -37.54%1.42M | 232.64%642K | -61.58%292K | 89.06%363K | -89.48%118K | 4,021.82%2.27M | 162.26%193K |
| Net income attributable to the company | 304.77%101.03M | 42.63%2.8M | 868.50%25.65M | 87.27%-80.16M | 94.50%-35.43M | -252.75%-49.34M | 171.61%1.96M | -90.45%2.65M | -465.91%-629.92M | -853.89%-644.39M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 304.77%101.03M | 42.63%2.8M | 868.50%25.65M | 87.27%-80.16M | 94.50%-35.43M | -252.75%-49.34M | 171.61%1.96M | -90.45%2.65M | -465.91%-629.92M | -853.89%-644.39M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 291.01%0.0701 | 26.67%0.0019 | 790.00%0.0178 | 87.81%-0.0586 | 94.86%-0.0253 | -242.99%-0.0367 | 150.00%0.0015 | -90.57%0.002 | -465.70%-0.4809 | -853.29%-0.4919 |
| Diluted earnings per share | 291.01%0.0701 | 26.67%0.0019 | 790.00%0.0178 | 87.81%-0.0586 | 94.86%-0.0253 | -242.99%-0.0367 | 150.00%0.0015 | -90.57%0.002 | -465.70%-0.4809 | -853.29%-0.4919 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 53.33%0.069 | -70.00%0.006 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
MY
Overall
Symbol
Latest Price
% Chg
No Data